Drug-class overview:@0.657199:0.039086:0.902803:0.039086:0.902803:0.019651:0.657199:0.019651:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
65:@0.950592:0.038665:0.976698:0.038665:0.976698:0.018632:0.950592:0.018632:0.000000:0.000000
Drug-class overview:@0.981851:0.292741:0.981851:0.109337:0.953582:0.109337:0.953582:0.292741:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
MIMS ConCISe GuIde to CardIovaSCular, MetabolIC and endoCrIne dISeaSeS :@0.216640:0.974259:0.820834:0.974259:0.820834:0.960936:0.216640:0.960936:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.820834:0.974259:0.824580:0.974259:0.824580:0.960936:0.820834:0.960936:0.000000
VOLUME 1:@0.824751:0.974259:0.906065:0.974259:0.906065:0.959690:0.824751:0.959690:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
dose/discontinue if  hypocalcaemia persists :@0.096970:0.096562:0.479990:0.096562:0.479990:0.081574:0.096970:0.081574:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.475756:0.096562:0.479970:0.096562:0.479970:0.081574:0.475756:0.081574:0.000000
:@0.096970:0.111869:0.105783:0.111869:0.105783:0.097184:0.096970:0.097184:0.000000
 reduce dose/discontinue if PtH level decreases :@0.105783:0.112385:0.479990:0.112385:0.479990:0.097396:0.105783:0.097396:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
below recommended target   Moderate to severe :@0.096989:0.128207:0.480009:0.128207:0.480009:0.113218:0.096989:0.113218:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.316468:0.127691:0.325281:0.127691:0.325281:0.113006:0.316468:0.113006:0.000000
hepatic impairment    use in pregnancy only :@0.096989:0.144029:0.480009:0.144029:0.480009:0.129040:0.096989:0.129040:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.266072:0.143513:0.274885:0.143513:0.274885:0.128828:0.266072:0.128828:0.000000
if potential benefit justifies  potential foetal risk :@0.097008:0.159705:0.480047:0.159705:0.480047:0.144717:0.097008:0.144717:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.475795:0.159705:0.480009:0.159705:0.480009:0.144717:0.475795:0.144717:0.000000
:@0.097008:0.174866:0.105821:0.174866:0.105821:0.160182:0.097008:0.160182:0.000000
 excreted in milk of lactating rats:@0.105821:0.175382:0.353317:0.175382:0.353317:0.160393:0.105821:0.160393:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Drug interactions: :@0.097008:0.195080:0.255854:0.195080:0.255854:0.178689:0.097008:0.178689:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Increased level with concomitant strong :@0.097008:0.210757:0.480028:0.210757:0.480028:0.195768:0.097008:0.195768:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
CYP3a4  inhibitors   Possible  dose adjustment :@0.097008:0.226433:0.480028:0.226433:0.480028:0.211445:0.097008:0.211445:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.249735:0.225917:0.258548:0.225917:0.258548:0.211233:0.249735:0.211233:0.000000
required with strong CYP3a4 inducers/strong :@0.097008:0.242110:0.480028:0.242110:0.480028:0.227121:0.097008:0.227121:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
CYP1a2 inhibitors and medicines metabolised :@0.097008:0.257786:0.479990:0.257786:0.479990:0.242798:0.097008:0.242798:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
predominantly by CYP2d6 enzyme:@0.097008:0.273463:0.365555:0.273463:0.365555:0.258474:0.097008:0.258474:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
REfEREnCES:@0.097200:0.304816:0.209845:0.304816:0.209845:0.288425:0.097200:0.288425:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1.   Marcocci C, :@0.096970:0.318841:0.209858:0.318841:0.209858:0.305518:0.096970:0.305518:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
et al.,:@0.210594:0.318841:0.244512:0.318841:0.244512:0.305753:0.210594:0.305753:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 Medical management of primary :@0.244512:0.318841:0.479509:0.318841:0.479509:0.305518:0.244512:0.305518:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
hyperparathyroidism: Proceedings of the fourth :@0.127278:0.333199:0.479509:0.333199:0.479509:0.319876:0.127278:0.319876:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
International  Workshop on the Management of :@0.127278:0.347557:0.479509:0.347557:0.479509:0.334234:0.127278:0.334234:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
asymptomatic Primary Hyperparathyroidism. :@0.127278:0.361915:0.439553:0.361915:0.439553:0.348592:0.127278:0.348592:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
J Clin :@0.440767:0.361915:0.478841:0.361915:0.478841:0.348827:0.440767:0.348827:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Endocrinol Metab.:@0.127278:0.376273:0.245418:0.376273:0.245418:0.363185:0.127278:0.363185:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 2014; 99(10):3607-18.:@0.245418:0.376273:0.392858:0.376273:0.392858:0.362950:0.245418:0.362950:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
2.   Snyman Jr, ed. Hormone inhibitors. :@0.096970:0.390632:0.368929:0.390632:0.368929:0.377308:0.096970:0.377308:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Monthly Index of :@0.368210:0.390632:0.478841:0.390632:0.478841:0.377543:0.368210:0.377543:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Medical Specialities.:@0.127278:0.404990:0.255801:0.404990:0.255801:0.391902:0.127278:0.391902:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 2020;60(3).:@0.255801:0.404990:0.332993:0.404990:0.332993:0.391666:0.255801:0.391666:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Male HYPogonaDisM  :@0.097226:0.438450:0.375728:0.438450:0.375728:0.416895:0.097226:0.416895:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
in elDerlY Patients:@0.097226:0.457958:0.340681:0.457958:0.340681:0.436404:0.097226:0.436404:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
once the diagnosis of hypogonadism is made, :@0.096970:0.472527:0.480009:0.472527:0.480009:0.457539:0.096970:0.457539:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
a definitive diagnosis of the cause of low :@0.096970:0.488204:0.479932:0.488204:0.479932:0.473215:0.096970:0.473215:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
testosterone levels needs to be made. :@0.096970:0.503881:0.391090:0.503881:0.391090:0.488892:0.096970:0.488892:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
the decision to treat with testosterone-:@0.115154:0.519557:0.475776:0.519557:0.475776:0.504568:0.115154:0.504568:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
replacement therapy is one of balancing :@0.096970:0.535234:0.479970:0.535234:0.479970:0.520245:0.096970:0.520245:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
moderate short-term clinical benefit against :@0.096970:0.550910:0.479970:0.550910:0.479970:0.535922:0.096970:0.535922:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
unknown possible long-term adverse effects, :@0.096970:0.566587:0.479951:0.566587:0.479951:0.551598:0.096970:0.551598:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
particularly in relation to cardiovascular and :@0.096970:0.582263:0.479951:0.582263:0.479951:0.567275:0.096970:0.567275:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
prostate health. Several forms of injectable :@0.096970:0.597940:0.480009:0.597940:0.480009:0.582951:0.096970:0.582951:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
testosterone preparations, as well as a topical :@0.096970:0.613616:0.479990:0.613616:0.479990:0.598628:0.096970:0.598628:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
testosterone gel, are available in South africa.:@0.096970:0.629293:0.442621:0.629293:0.442621:0.614304:0.096970:0.614304:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1:@0.442615:0.623535:0.448090:0.623535:0.448090:0.614796:0.442615:0.614796:0.000000
Clomiphene citrate has been used empirically :@0.115151:0.644998:0.479987:0.644998:0.479987:0.630010:0.115151:0.630010:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
in men with hypogonadotropic hypogonadism :@0.096967:0.660675:0.479987:0.660675:0.479987:0.645686:0.096967:0.645686:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
and although there are no data from large :@0.096967:0.676352:0.479930:0.676352:0.479930:0.661363:0.096967:0.661363:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
randomised controlled trials showing safety and :@0.096967:0.692028:0.480007:0.692028:0.480007:0.677039:0.096967:0.677039:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
efficacy, data from small studies show it to be :@0.096967:0.707705:0.479968:0.707705:0.479968:0.692716:0.096967:0.692716:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
effective in elevating testosterone levels.:@0.096967:0.723381:0.406501:0.723381:0.406501:0.708393:0.096967:0.708393:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
2:@0.406497:0.717610:0.411972:0.717610:0.411972:0.708871:0.406497:0.708871:0.000000
testosterone:@0.096970:0.752331:0.239799:0.752331:0.239799:0.730776:0.096970:0.730776:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
3:@0.239798:0.744618:0.247815:0.744618:0.247815:0.732052:0.239798:0.732052:0.000000
Indications: :@0.096970:0.771368:0.201244:0.771368:0.201244:0.754977:0.096970:0.754977:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Hypogonadism  due  to  androgen  deficiency  in :@0.096970:0.787045:0.479932:0.787045:0.479932:0.772056:0.096970:0.772056:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
men :@0.096970:0.802722:0.136590:0.802722:0.136590:0.787733:0.096970:0.787733:0.000000:0.000000:0.000000:0.000000
Dosage: :@0.096970:0.822420:0.170283:0.822420:0.170283:0.806029:0.096970:0.806029:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
depends on formulation. Please refer to product :@0.096970:0.838096:0.479951:0.838096:0.479951:0.823108:0.096970:0.823108:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
literature:@0.096970:0.853773:0.165607:0.853773:0.165607:0.838784:0.096970:0.838784:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Contraindications::@0.096970:0.873908:0.254757:0.873908:0.254757:0.857517:0.096970:0.857517:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Male breast cancer   Known/suspected prostate :@0.096970:0.889584:0.479970:0.889584:0.479970:0.874596:0.096970:0.874596:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.251101:0.889068:0.259914:0.889068:0.259914:0.874384:0.251101:0.874384:0.000000
cancer   Cardiac/hepatic/renal decompensation :@0.096970:0.905261:0.480009:0.905261:0.480009:0.890272:0.096970:0.890272:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.155466:0.904745:0.164279:0.904745:0.164279:0.890060:0.155466:0.890060:0.000000
:@0.096989:0.920421:0.105802:0.920421:0.105802:0.905737:0.096989:0.905737:0.000000
 Hypercalcaemia   Impaired liver function :@0.105802:0.920937:0.480009:0.920937:0.480009:0.905949:0.105802:0.905949:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.257855:0.920421:0.266668:0.920421:0.266668:0.905737:0.257855:0.905737:0.000000
 :@0.475795:0.920937:0.480009:0.920937:0.480009:0.905949:0.475795:0.905949:0.000000
:@0.097008:0.936098:0.105821:0.936098:0.105821:0.921414:0.097008:0.921414:0.000000
 Prepubertal males   Pregnancy:@0.105821:0.936614:0.347486:0.936614:0.347486:0.921625:0.105821:0.921625:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.253333:0.936098:0.262146:0.936098:0.262146:0.921414:0.253333:0.921414:0.000000
Side effects: :@0.524286:0.096535:0.631389:0.096535:0.631389:0.080144:0.524286:0.080144:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Priapism   Hypercalcaemia   Female virilisation :@0.524286:0.111974:0.907325:0.111974:0.907325:0.096985:0.524286:0.096985:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.597772:0.111458:0.606585:0.111458:0.606585:0.096774:0.597772:0.096774:0.000000
:@0.745593:0.111458:0.754406:0.111458:0.754406:0.096774:0.745593:0.096774:0.000000
:@0.524305:0.127042:0.533118:0.127042:0.533118:0.112358:0.524305:0.112358:0.000000
  voice  changes    oedema    oligiospermia/:@0.533118:0.127558:0.903092:0.127558:0.903092:0.112569:0.533118:0.112569:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.671933:0.127042:0.680746:0.127042:0.680746:0.112358:0.671933:0.112358:0.000000
:@0.769453:0.127042:0.778266:0.127042:0.778266:0.112358:0.769453:0.112358:0.000000
reduced ejaculate volume after prolonged :@0.524305:0.142851:0.907286:0.142851:0.907286:0.127862:0.524305:0.127862:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
administration/excessive doses   Hypersensitivity :@0.524305:0.157998:0.907306:0.157998:0.907306:0.143009:0.524305:0.143009:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.767779:0.157482:0.776592:0.157482:0.776592:0.142798:0.767779:0.142798:0.000000
:@0.524305:0.172630:0.533118:0.172630:0.533118:0.157945:0.524305:0.157945:0.000000
 Gynaecomastia   acne   Skin reactions   local :@0.533118:0.173146:0.907325:0.173146:0.907325:0.158157:0.533118:0.158157:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.662350:0.172630:0.671163:0.172630:0.671163:0.157945:0.662350:0.157945:0.000000
:@0.721540:0.172630:0.730353:0.172630:0.730353:0.157945:0.721540:0.157945:0.000000
:@0.848828:0.172630:0.857641:0.172630:0.857641:0.157945:0.848828:0.157945:0.000000
irritation:@0.524324:0.188293:0.589190:0.188293:0.589190:0.173304:0.524324:0.173304:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Special precautions: :@0.524324:0.207462:0.700642:0.207462:0.700642:0.191071:0.524324:0.191071:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
thrombophilia   Immobilised patients   organic :@0.524324:0.222609:0.907344:0.222609:0.907344:0.207621:0.524324:0.207621:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.643512:0.222093:0.652325:0.222093:0.652325:0.207409:0.643512:0.207409:0.000000
:@0.827912:0.222093:0.836725:0.222093:0.836725:0.207409:0.827912:0.207409:0.000000
heart disease. Hypertension   Sleep apnoea :@0.524343:0.237757:0.907363:0.237757:0.907363:0.222768:0.524343:0.222768:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.767837:0.237241:0.776650:0.237241:0.776650:0.222556:0.767837:0.222556:0.000000
 :@0.903130:0.237757:0.907344:0.237757:0.907344:0.222768:0.903130:0.222768:0.000000
:@0.524343:0.252388:0.533156:0.252388:0.533156:0.237704:0.524343:0.237704:0.000000
 bleeding disorder   elderly   Women:@0.533156:0.252904:0.818079:0.252904:0.818079:0.237916:0.533156:0.237916:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.676378:0.252388:0.685191:0.252388:0.685191:0.237704:0.676378:0.237704:0.000000
:@0.744823:0.252388:0.753636:0.252388:0.753636:0.237704:0.744823:0.237704:0.000000
REfEREnCES:@0.524536:0.283199:0.637181:0.283199:0.637181:0.266808:0.524536:0.266808:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1.   bhasin  S, :@0.524242:0.296522:0.620591:0.296522:0.620591:0.283198:0.524242:0.283198:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
et al.:@0.623533:0.296522:0.656185:0.296522:0.656185:0.283434:0.623533:0.283434:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 testosterone therapy in men with :@0.656185:0.296522:0.906747:0.296522:0.906747:0.283198:0.656185:0.283198:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
hypogonadism:  an  endocrine Society clinical :@0.554534:0.310045:0.906747:0.310045:0.906747:0.296722:0.554534:0.296722:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
practice guideline.:@0.554534:0.323721:0.684784:0.323721:0.684784:0.310398:0.554534:0.310398:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 J Clin Endocrinol Metab.:@0.684784:0.323721:0.858273:0.323721:0.858273:0.310633:0.684784:0.310633:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 2018; :@0.858273:0.323721:0.906747:0.323721:0.906747:0.310398:0.858273:0.310398:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
103(5):1715-1744.:@0.554534:0.337244:0.674812:0.337244:0.674812:0.323921:0.554534:0.323921:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
2.   Katz  dJ, :@0.524225:0.350920:0.616075:0.350920:0.616075:0.337597:0.524225:0.337597:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
et al.:@0.621549:0.350920:0.656271:0.350920:0.656271:0.337832:0.621549:0.337832:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
  outcomes  of  clomiphene  citrate :@0.656271:0.350920:0.906730:0.350920:0.906730:0.337597:0.656271:0.337597:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
treatment in young hypogonadal men. :@0.554517:0.364596:0.845325:0.364596:0.845325:0.351273:0.554517:0.351273:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
BJU Int.:@0.850696:0.364596:0.902984:0.364596:0.902984:0.351508:0.850696:0.351508:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.902984:0.364596:0.906730:0.364596:0.906730:0.351273:0.902984:0.351273:0.000000
2012;110(4):573-8.:@0.554517:0.378119:0.677771:0.378119:0.677771:0.364796:0.554517:0.364796:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
3.   Snyman Jr, ed. endocrine system. :@0.524208:0.391795:0.791190:0.391795:0.791190:0.378472:0.524208:0.378472:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Monthly Index of :@0.792319:0.391795:0.906063:0.391795:0.906063:0.378707:0.792319:0.378707:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Medical Specialities. :@0.554517:0.405471:0.686118:0.405471:0.686118:0.392383:0.554517:0.392383:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
2020;60(3).:@0.686118:0.405471:0.759564:0.405471:0.759564:0.392148:0.686118:0.392148:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
seXual DYsfunCtion  :@0.524498:0.438719:0.798818:0.438719:0.798818:0.417164:0.524498:0.417164:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
anD tHe ageing Male :@0.524498:0.457980:0.798305:0.457980:0.798305:0.436426:0.524498:0.436426:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
an oral phosphodiesterase type-5 inhibitor is the :@0.524242:0.472024:0.907204:0.472024:0.907204:0.457035:0.524242:0.457035:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
first-line drug treatment for erectile dysfunction, :@0.524242:0.487171:0.907243:0.487171:0.907243:0.472182:0.524242:0.472182:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
regardless of the cause.  these drugs act by :@0.524242:0.502318:0.907243:0.502318:0.907243:0.487330:0.524242:0.487330:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
increasing the blood flow to the penis. :@0.524242:0.517466:0.823019:0.517466:0.823019:0.502477:0.524242:0.502477:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
oral PDe-5 inhibitors:@0.524242:0.546158:0.755664:0.546158:0.755664:0.524603:0.524242:0.524603:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Sildenafil:@0.524242:0.573304:0.624097:0.573304:0.624097:0.551750:0.524242:0.551750:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
3:@0.624095:0.565599:0.631858:0.565599:0.631858:0.553033:0.624095:0.553033:0.000000
Indications: :@0.524242:0.591375:0.628517:0.591375:0.628517:0.574984:0.524242:0.574984:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
erectile dysfunction:@0.524242:0.606522:0.675391:0.606522:0.675391:0.591534:0.524242:0.591534:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Dosage: :@0.524242:0.625691:0.597556:0.625691:0.597556:0.609301:0.524242:0.609301:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Initially 50 mg, to be taken approximately 1 hour :@0.524242:0.640839:0.907281:0.640839:0.907281:0.625850:0.524242:0.625850:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
before sexual activity, adjusted according to :@0.524242:0.655986:0.907281:0.655986:0.907281:0.640998:0.524242:0.640998:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
response to 25-100 mg (maximum per dose :@0.524242:0.671134:0.907204:0.671134:0.907204:0.656145:0.524242:0.656145:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
100 mg) as required, to be taken as a single dose; :@0.524242:0.686281:0.907224:0.686281:0.907224:0.671292:0.524242:0.671292:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
maximum 1 dose per day:@0.524242:0.701428:0.719398:0.701428:0.719398:0.686440:0.524242:0.686440:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Contraindications: :@0.524242:0.720598:0.685917:0.720598:0.685917:0.704207:0.524242:0.704207:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Concomitant:@0.524242:0.735745:0.625188:0.735745:0.625188:0.720756:0.524242:0.720756:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
nitric:@0.651550:0.735745:0.690246:0.735745:0.690246:0.720756:0.651550:0.720756:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
oxide:@0.716608:0.735745:0.758768:0.735745:0.758768:0.720756:0.716608:0.720756:0.000000:0.000000:0.000000:0.000000:0.000000
donors/nitrates :@0.785131:0.735745:0.907243:0.735745:0.907243:0.720756:0.785131:0.720756:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.524242:0.750376:0.533055:0.750376:0.533055:0.735692:0.524242:0.735692:0.000000
 Hepatic impairment/severe renal impairment :@0.533055:0.750892:0.907262:0.750892:0.907262:0.735904:0.533055:0.735904:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903048:0.750892:0.907262:0.750892:0.907262:0.735904:0.903048:0.735904:0.000000
:@0.524261:0.765524:0.533074:0.765524:0.533074:0.750839:0.524261:0.750839:0.000000
 Men in whom sexual activity is inadvised :@0.533074:0.766040:0.907320:0.766040:0.907320:0.751051:0.533074:0.751051:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
because of underlying cardiovascular status :@0.524261:0.781187:0.907281:0.781187:0.907281:0.766198:0.524261:0.766198:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903048:0.781187:0.907262:0.781187:0.907262:0.766198:0.903048:0.766198:0.000000
:@0.524261:0.795819:0.533074:0.795819:0.533074:0.781134:0.524261:0.781134:0.000000
 Safety and efficacy of combinations with other :@0.533074:0.796334:0.907243:0.796334:0.907243:0.781346:0.533074:0.781346:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
treatments of erectile dysfunction not studied  :@0.524261:0.811482:0.907262:0.811482:0.907262:0.796493:0.524261:0.796493:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.524261:0.826113:0.533074:0.826113:0.533074:0.811429:0.524261:0.811429:0.000000
 Concomitant HIv protease inhibitors/ritonavir  :@0.533074:0.826629:0.907281:0.826629:0.907281:0.811641:0.533074:0.811641:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.524280:0.841261:0.533094:0.841261:0.533094:0.826576:0.524280:0.826576:0.000000
 Women   Children:@0.533094:0.841777:0.679759:0.841777:0.679759:0.826788:0.533094:0.826788:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.601770:0.841261:0.610583:0.841261:0.610583:0.826576:0.601770:0.826576:0.000000
Side effects: :@0.524300:0.860946:0.631403:0.860946:0.631403:0.844555:0.524300:0.844555:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Headaches    nasal complaints    vasodilation :@0.524300:0.876093:0.907320:0.876093:0.907320:0.861104:0.524300:0.861104:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.620569:0.875577:0.629383:0.875577:0.629383:0.860893:0.620569:0.860893:0.000000
:@0.790268:0.875577:0.799081:0.875577:0.799081:0.860893:0.790268:0.860893:0.000000
 :@0.903106:0.876093:0.907320:0.876093:0.907320:0.861104:0.903106:0.861104:0.000000
:@0.524319:0.890725:0.533132:0.890725:0.533132:0.876040:0.524319:0.876040:0.000000
 asthenia   dizziness   drowsiness   dyspnoea :@0.533132:0.891241:0.907301:0.891241:0.907301:0.876252:0.533132:0.876252:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.612007:0.890725:0.620820:0.890725:0.620820:0.876040:0.612007:0.876040:0.000000
:@0.702754:0.890725:0.711567:0.890725:0.711567:0.876040:0.702754:0.876040:0.000000
:@0.810646:0.890725:0.819459:0.890725:0.819459:0.876040:0.810646:0.876040:0.000000
 :@0.903086:0.891241:0.907301:0.891241:0.907301:0.876252:0.903086:0.876252:0.000000
:@0.524300:0.905872:0.533113:0.905872:0.533113:0.891188:0.524300:0.891188:0.000000
  exertional :@0.533113:0.906388:0.632307:0.906388:0.632307:0.891399:0.533113:0.891399:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.647220:0.905872:0.656033:0.905872:0.656033:0.891188:0.647220:0.891188:0.000000
 Gastro-intestinal  discomfort :@0.656014:0.906388:0.907320:0.906388:0.907320:0.891399:0.656014:0.891399:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903106:0.906388:0.907320:0.906388:0.907320:0.891399:0.903106:0.891399:0.000000
:@0.524319:0.921019:0.533132:0.921019:0.533132:0.906335:0.524319:0.906335:0.000000
 Muscle complaints :@0.533132:0.921535:0.718552:0.921535:0.718552:0.906547:0.533132:0.906547:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.734966:0.921019:0.743779:0.921019:0.743779:0.906335:0.734966:0.906335:0.000000
  nausea :@0.743779:0.921535:0.825116:0.921535:0.825116:0.906547:0.743779:0.906547:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.841549:0.921019:0.850362:0.921019:0.850362:0.906335:0.841549:0.906335:0.000000
 Pain :@0.850343:0.921535:0.907358:0.921535:0.907358:0.906547:0.850343:0.906547:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903144:0.921535:0.907358:0.921535:0.907358:0.906547:0.903144:0.906547:0.000000
:@0.524357:0.936167:0.533170:0.936167:0.533170:0.921482:0.524357:0.921482:0.000000
 Palpitations    respiratory disorders    blurred :@0.533170:0.936683:0.907358:0.936683:0.907358:0.921694:0.533170:0.921694:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.639485:0.936167:0.648298:0.936167:0.648298:0.921482:0.639485:0.921482:0.000000
:@0.830562:0.936167:0.839375:0.936167:0.839375:0.921482:0.830562:0.921482:0.000000